Standard BioTools Completes Microfluidics Business Sale to ARCHIMED
Standard BioTools completed the sale of its microfluidics business to ARCHIMED.
Related stories
NNPC CEO Says IPO Likely to List 5% to 10% Stake
CEO Bashir Bayo Ojulari told Reuters the offering would focus primarily on Nigeria's domestic market, with a potential secondary listing in London or New York.
L impact | MNA | Nov 03, 2026, 01:44 PM UTC
Preservium Board Urges Shareholders to Reject PPI Offer
M impact | MNA | Nov 03, 2026, 01:41 PM UTC
Star Equity übernimmt Cornerstone RPO über Hudson Talent Solutions
M impact | MNA | Nov 03, 2026, 01:38 PM UTC
International Seaways Completes Acquisition of Bruton Limited
M impact | MNA | Nov 03, 2026, 01:35 PM UTC
OppFi Withdraws Federal Applications for Proposed BNC Acquisition
OppFi withdrew applications to the OCC, Federal Reserve and FDIC related to its proposed acquisition of BNCCORP and BNC National Bank. The company reaffirmed revised full-year 2026
M impact | MNA | Nov 03, 2026, 01:32 PM UTC
Haniel’s CECONOMY Stake Sale to JD.com Clears Final Regulatory Hurdle
The European Commission cleared the final regulatory hurdle for Haniel’s CECONOMY stake sale to JD.com.
M impact | MNA | Nov 03, 2026, 01:27 PM UTC